Cover Image
市場調查報告書

全球腫瘤切除市場規模及預測:各技術 (高頻、微波、冷凍切除) 、各治療 (外科、腹腔鏡、經皮) 、各用途 (肝癌症、乳癌、肺癌、前列腺癌) ,及2015∼2022年趨勢分析

Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver/Breast/Lung/Prostrate Cancer), And Trend Analysis From 2015 To 2022

出版商 Grand View Research, Inc. 商品編碼 355240
出版日期 內容資訊 英文 80 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球腫瘤切除市場規模及預測:各技術 (高頻、微波、冷凍切除) 、各治療 (外科、腹腔鏡、經皮) 、各用途 (肝癌症、乳癌、肺癌、前列腺癌) ,及2015∼2022年趨勢分析 Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver/Breast/Lung/Prostrate Cancer), And Trend Analysis From 2015 To 2022
出版日期: 2016年02月28日 內容資訊: 英文 80 Pages
簡介

全球腫瘤切除市場,預計至2022年達到15億美元。各種癌症的罹患率上升和技術的進步帶動市場成長。熱感切除,加上雷射消熔和不可逆的電穿孔,HIFU等技術在臨床也擴大,推動腫瘤切除產業的擴大。

本報告提供全球腫瘤切除市場現狀與至2022年的成長預測,各技術,各地區趨勢,及主要企業的簡介等彙整。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 產業分析:波特
  • PESTEL分析
  • 競爭環境

第4章 各技術市場預測

  • 各技術收益佔有率
  • 射頻消融術設備
  • 微波切除設備
  • 冷凍切除設備
  • 其他

第5章 各治療預測

  • 各治療市場佔有率
  • 外科的切除
  • 腹腔鏡的切除

第6章 各用途預測

  • 各用途市場佔有率
  • 肝癌症
  • 乳癌
  • 肺癌
  • 前列腺癌
  • 其他癌症

第7章 各地區市場預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭環境

  • Medtronic Plc.
  • Angiodynamics
  • Mermaid Medical
  • HealthTronics
  • Galil Medical Inc.
  • EDAP TMS S.A.
  • Boston Scientific Corporation
  • SonaCare Medical
  • Misonix, Inc.
  • Neuwave Medical, Inc.

圖表

目錄
Product Code: 978-1-68038-746-9

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market.

Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.

Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.

In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth.

The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in profit for the former company.

Further key findings from the study suggest:

Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.

In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.

Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.

According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.

Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical.

Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Tumor Ablation Devices Market- Industry Snapshot and Key Buying Criteria, 2014

Chapter 3. Tumor Ablation Devices Industry Outlook

  • 3.1. Tumor Ablation Devices Market Segmentation
  • 3.2. Tumor Ablation Devices Market Size and Growth Prospects
  • 3.3. Tumor Ablation Devices Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Industry Analysis - Porter's
  • 3.5. Tumor Ablation Devices Market PESTEL Analysis, 2014
  • 3.6. Competitive Landscape

Chapter 4. Tumor Ablation Devices Technology Outlook

  • 4.1. Tumor Ablation Devices Market Share By Technology, 2014 & 2022
  • 4.2. Radiofrequency Ablation Devices
    • 4.2.1. Radiofrequency Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 4.3. Microwave Ablation Devices
    • 4.3.1. Tumor Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 4.4. Cryoablation Devices
    • 4.4.1. Cryoablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 4.5. Other Ablation Devices
    • 4.5.1. Other Ablation Devices Market Estimates and Forecasts, 2015 - 2022

Chapter 5. Tumor Ablation Devices Treatment Outlook

  • 5.1. Tumor Ablation Devices Market Share By Treatment, 2014 & 2022
  • 5.2. Surgical Ablation
    • 5.2.1. Surgical Ablation Market Estimates and Forecasts, 2015 - 2022
  • 5.3. Laparoscopic Ablation
    • 5.3.1. Laparoscopic Ablation Market Estimates and Forecasts, 2015 - 2022
  • 5.4. Percutaneous Ablation
    • 5.4.1. Percutaneous Ablation Market Estimates and Forecasts, 2015 - 2022

Chapter 6. Tumor Ablation Devices Application Outlook

  • 6.1. Tumor Ablation Devices Market Share By Application, 2014 & 2022
  • 6.2. Liver Cancer
    • 6.2.1. Liver Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 6.3. Breast Cancer
    • 6.3.1. Breast Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 6.4. Lung Cancer
    • 6.4.1. Lung Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 6.5. Prostrate Metastasis
    • 6.5.1. Prostrate Metastasis Ablation Devices Market Estimates and Forecasts, 2015 - 2022
  • 6.6. Other Cancer
    • 6.6.1. Other Cancer Ablation Devices Market Estimates and Forecasts, 2015 - 2022

Chapter 7. Tumor Ablation Devices Regional Outlook

  • 7.1. Tumor Ablation Devices Market Share By Region, 2014 & 2022
  • 7.2. North America
    • 7.2.1. North America Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
      • 7.2.1.1. U.S. Market Estimates and Forecasts
      • 7.2.1.2. Canada Market Estimates and Forecasts
    • 7.2.2. North America Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
      • 7.2.2.1. U.S. Market Estimates and Forecasts
      • 7.2.2.2. Canada Market Estimates and Forecasts
    • 7.2.3. North America Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
      • 7.2.3.1. U.S. Market Estimates and Forecasts
      • 7.2.3.2. Canada Market Estimates and Forecasts
  • 7.3. Europe
    • 7.3.1. Europe Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
      • 7.3.1.1. Germany Market Estimates and Forecasts
      • 7.3.1.2. UK Market Estimates and Forecasts
    • 7.3.2. Europe Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
      • 7.3.2.1. Germany Market Estimates and Forecasts
      • 7.3.2.2. UK Market Estimates and Forecasts
    • 7.3.3. Europe Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
      • 7.3.3.1. Germany Market Estimates and Forecasts
      • 7.3.3.2. UK Market Estimates and Forecasts
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
      • 7.4.1.1. Japan Market Estimates and Forecasts
      • 7.4.1.2. China Market Estimates and Forecasts
    • 7.4.2. Asia Pacific Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
      • 7.4.2.1. Japan Market Estimates and Forecasts
      • 7.4.2.2. China Market Estimates and Forecasts
    • 7.4.3. Asia Pacific Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
      • 7.4.3.1. Japan Market Estimates and Forecasts
      • 7.4.3.2. China Market Estimates and Forecasts
  • 7.5. Latin America
    • 7.5.1. Latin America Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
      • 7.5.1.1. Mexico Estimates and Forecasts
      • 7.5.1.2. Brazil Estimates and Forecasts
    • 7.5.2. Latin America Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
      • 7.5.2.1. Mexico Estimates and Forecasts
      • 7.5.2.2. Brazil Estimates and Forecasts
    • 7.5.3. Latin America Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
      • 7.5.3.1. Mexico Estimates and Forecasts
      • 7.5.3.2. Brazil Estimates and Forecasts
  • 7.6. MEA
    • 7.6.1. MEA Market Estimates and Forecasts, by Technology, 2015 - 2022 (USD Million)
      • 7.6.1.1. South Africa Estimates and Forecasts
      • 7.6.1.2. Saudi Arabia Estimates and Forecasts
    • 7.6.2. MEA Market Estimates and Forecasts, by Treatment, 2015 - 2022 (USD Million)
      • 7.6.2.1. South Africa Estimates and Forecasts
      • 7.6.2.2. Saudi Arabia Estimates and Forecasts
    • 7.6.3. MEA Market Estimates and Forecasts, by Application, 2015 - 2022 (USD Million)
      • 7.6.3.1. South Africa Estimates and Forecasts
      • 7.6.3.2. Saudi Arabia Estimates and Forecasts

Chapter 8. Competitive Landscape

  • 8.1. Medtronic Plc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. Angiodynamics
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Strategic Initiatives
  • 8.3. Mermaid Medical
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic Initiatives
  • 8.4. HealthTronics
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. Galil Medical Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. EDAP TMS S.A.
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. Boston Scientific Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic Initiatives
  • 8.8. SonaCare Medical
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic Initiatives
  • 8.9. Misonix, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Initiatives
  • 8.10. Neuwave Medical, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: Tumor ablation market - Industry Summary & Key Buying Criteria
  • TABLE 2: Tumor ablation market, by technology, 2015 - 2022 (USD million)
  • TABLE 3: Tumor ablation market, by treatment, 2015 - 2022 (USD million)
  • TABLE 4: Tumor ablation market, by application, 2015 - 2022 (USD million)
  • TABLE 5: Tumor ablation market, by region, 2015 - 2022 (USD Million)
  • TABLE 6: Tumor ablation - Key market driver analysis
  • TABLE 7: Tumor ablation - Key market restraint analysis
  • TABLE 8: North America tumor ablation market, by region 2015 - 2022 (USD Million)
  • TABLE 9: North America tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 10: North America tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 11: North America tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 12: U.S. tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 13: U.S. tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 14: U.S. tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 15: Canada Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 16: Canada Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 17: Canada tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 18: Europe tumor ablation market, by region 2015 - 2022 (USD Million)
  • TABLE 19: Europe tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 20: Europe tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 21: Europe tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 22: UK Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 23: UK Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 24: UK tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 25: Germany Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 26: Germany Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 27: Germany tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 28: Latin America tumor ablation market, by region 2015 - 2022 (USD Million)
  • TABLE 29: Latin America tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 30: Latin America tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 31: Latin America tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 32: Brazil Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 33: Brazil Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 34: Brazil tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 35: Mexico Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 36: Mexico Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 37: Mexico tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 38: MEA tumor ablation market, by region 2015 - 2022 (USD Million)
  • TABLE 39: MEA tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 40: MEA tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 41: MEA tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 42: South Africa Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 43: South Africa Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 44: South Africa tumor ablation market, by application 2015 - 2022 (USD Million)
  • TABLE 45: Saudi Arabia Tumor ablation market, by technology2015 - 2022 (USD Million)
  • TABLE 46: Saudi Arabia Tumor ablation market, by treatment 2015 - 2022 (USD Million)
  • TABLE 47: Saudi Arabia tumor ablation market, by application 2015 - 2022 (USD Million)

List of Figures

  • FIG. 1: Global tumor ablation: Market segmentation
  • FIG. 2: Global tumor ablation market, 2012 - 2020 (USD Million)
  • FIG. 3: Tumor ablation: Market dynamics
  • FIG. 4: Tumor ablation market - Porter's analysis
  • FIG. 5: Key opportunities prioritized
  • FIG. 6: Tumor ablation market - PESTEL Analysis
  • FIG. 7: Tumor ablation market share, by technology, 2013 & 2020
  • FIG. 8: Radiofrequency ablation market, 2015 - 2022 (USD Million)
  • FIG. 9: Microwave ablation market, 2015 - 2022 (USD Million)
  • FIG. 10: Cryoablation market, 2015 - 2022 (USD Million)
  • FIG. 11: Other ablation technology market, 2015 - 2022 (USD Million)
  • FIG. 12: Tumor ablation market share, by treatment, 2013 & 2020
  • FIG. 13: Surgical ablation market, 2015 - 2022 (USD Million)
  • FIG. 14: Laparoscopic ablation market, 2015 - 2022 (USD Million)
  • FIG. 15: Percutaneous ablation market, 2015 - 2022 (USD Million)
  • FIG. 16: Tumor ablation market by application, 2015 - 2022 (USD Million)
  • FIG. 17: Liver cancer market, 2015 - 2022 (USD Million)
  • FIG. 18: Breast cancer market, 2015 - 2022 (USD Million)
  • FIG. 19: Lung cancer market, 2015 - 2022 (USD Million)
  • FIG. 20: Prostrate cancer market, 2015 - 2022 (USD Million)
  • FIG. 21: Other cancer market, 2015 - 2022 (USD Million)
  • FIG. 22: Tumor ablation market share, by region, 2013 & 2020
  • FIG. 23: North America Tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 24: U.S. tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 25: Canada tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 26: Europe tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 27: UK tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 28: Germany tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 29: Asia Pacific tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 30: Japan tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 31: China tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 32: Latin America tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 33: Mexico tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 34: Brazil tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 35: MEA tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 36: South Africa tumor ablation market, 2015 - 2022 (USD Million)
  • FIG. 37: Saudi Arabia tumor ablation market, 2015 - 2022 (USD Million)
Back to Top